Arkadios Wealth Advisors »

Crispr Therapeutics shares owned by Arkadios Wealth Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Arkadios Wealth Advisors from 13F filings

Historical chart of Arkadios Wealth Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Arkadios Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Arkadios Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $741k 11k 68.16
2023-12-31 $690k 11k 62.60
2023-09-30 $511k 11k 45.39
2023-06-30 $625k 11k 56.14
2023-03-31 $529k 12k 45.23
2022-12-31 $477k 12k 40.65
2022-09-30 $852k 13k 65.37
2022-06-30 $805k 13k 60.75
2022-03-31 $830k 13k 62.76
2021-12-31 $971k 13k 75.74
2021-09-30 $19k 170 111.76
2021-06-30 $27k 170 158.82
2020-12-31 $5.0k 34 147.06
2020-09-30 $2.2k 20 109.80
2020-06-30 $1.8k 20 90.90
2020-03-31 $848 20 42.40